In this paper, we investigate the following nonlinear and non-homogeneous elliptic system:where φ i (t) = a i (|t|)t(i = 1, 2) are two increasing homeomorphisms from R onto R, functions V i (i = 1, 2) and F are 1-periodic in x, and F satisfies some (φ 1 , φ 2 )-superlinear Orlicz-Sobolev conditions. By using a variant mountain pass lemma, we obtain that the system has a ground state.
MSC: 35J20; 35J50; 35J55; 35A15
In this paper, we investigate the following nonlinear and non-homogeneous elliptic systemwhere Ω is a bounded domain in R N (N 2) with smooth boundary ∂Ω, functions φ i (t)t (i = 1, 2) are increasing homeomorphisms from R + onto R + . When F satisfies some (φ 1 , φ 2 )-superlinear and subcritical growth conditions at infinity, by using the mountain pass theorem we obtain that system has a nontrivial solution, and when F satisfies an additional symmetric condition, by using the symmetric mountain pass theorem, we obtain that system has infinitely many solutions. Some of our results extend and improve those corresponding results in Carvalho et al. [M. L. M. Carvalho,
In this paper, we investigate the existence of multiple periodic solutions for two classes of nonlinear difference systems involving (φ 1 , φ 2 )-Laplacian. First, by using an important critical point theorem due to B. Ricceri, we establish an existence theorem of three periodic solutions for the first nonlinear difference system with (φ 1 , φ 2 )-Laplacian and two parameters. Moreover, for the second nonlinear difference system with (φ 1 , φ 2 )-Laplacian, by using the Clark's Theorem, we obtain a multiplicity result of periodic solutions under a symmetric condition. Finally, two examples are given to verify our theorems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.